Naloxone HCI IV

naloxone hydrochloride intravenous · Samjin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naloxone HCI IV, covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke [Phase 4]

See pricing